Firefly Neuroscience (AIFF)
NASDAQ:AIFF
Want to see AIFF full AI Analyst Report?
AIFF Stock Chart & Stats
$1.05
-$0.10(-4.05%)
At close: 4:00 PM EST
$1.05
-$0.10(-4.05%)
Day’s Range― - ―
52-Week Range$0.62 - $4.51
Previous CloseN/A
Volume11.65K
Average Volume (3M)316.76K
Market Cap
$33.58M
Enterprise Value$29.21M
Total Cash (Recent Filing)$2.75M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.29
Shares Outstanding14,793,075
10 Day Avg. Volume358,037
30 Day Avg. Volume316,761
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.51
Price to Sales (P/S)10.11
P/FCF Ratio-1.39
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue25.57
Enterprise Value/Gross Profit45.28
Enterprise Value/Ebitda-1.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthier Balance SheetFirefly’s 2025 balance sheet shows a clear structural improvement: positive equity of roughly $7.6M and no reported debt. This materially lowers solvency risk and gives management runway to invest in product and R&D without immediate refinancing pressure, improving medium-term viability.
Revenue & Margin RecoveryA 46% revenue rebound and a jump to ~56% gross margin indicate the business can scale core software/analytics revenue with improving unit economics. Higher gross margins increase operating leverage potential and make future profitability achievable as fixed costs are absorbed by growing revenue.
Capital Access FlexibilityAn ATM program plus completed private placements create durable financing optionality, enabling the company to access equity capital when needed and smooth working capital funding. This structural access reduces short-term liquidity shocks and supports ongoing R&D and commercialization efforts.
Bears Say
Persistent Cash BurnSustained negative operating and free cash flows of roughly -$8M annually signal structural cash consumption that must be financed externally. Over multiple quarters this undermines financial flexibility, forces repeated fundraising, and constrains the company’s ability to invest sustainably without dilution.
Very Large Net LossesA near-$20M net loss versus ~$1.1M revenue shows a structural mismatch: fixed and operating costs are disproportionate to current sales. Until revenue scales materially, profitability remains unlikely and margin recovery depends on meaningful, sustained top-line growth.
Dependence On Equity FinancingRepeated private placements, ATM program use and reliance on registration mechanics indicate recurring equity raises are a core funding model. This structurally increases dilution risk for shareholders and signals the company lacks self-sustaining cash generation in the near-to-medium term.
Firefly Neuroscience News
AIFF FAQ
What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $4.51 in the past 12 months.
What is Firefly Neuroscience’s market cap?
Firefly Neuroscience’s market cap is $33.58M.
When is Firefly Neuroscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Firefly Neuroscience’s earnings last quarter?
Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
Is Firefly Neuroscience overvalued?
According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued.
Does Firefly Neuroscience pay dividends?
Firefly Neuroscience does not currently pay dividends.
What is Firefly Neuroscience’s EPS estimate?
Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firefly Neuroscience have?
Firefly Neuroscience has 14,793,075 shares outstanding.
What happened to Firefly Neuroscience’s price movement after its last earnings report?
Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Firefly Neuroscience?
Currently, no hedge funds are holding shares in AIFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Firefly Neuroscience Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 961.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 2.6%
Last 30 Days ▲ 2.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.61%
12-Months-Change
Fundamentals
Return on Equity
-229.99%
Trailing 12-Months
Asset Growth
127.71%
Trailing 12-Months
Company Description
Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Technical Analysis
Ownership Overview
12.47% Insiders
3.59% Mutual Funds
0.08% Other Institutional Investors
82.88% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---